LYT-100 in Healthy Volunteers and BCRL
Status: TERMINATED
Study type: INTERVENTIONAL
Conditions: Breast Cancer Related Lymphoedema|Lymphoedema
Interventions: DRUG: LYT-100 MAD|OTHER: Matching Placebo for MAD|DRUG: LYT-100 Food Effect|DRUG: LYT-100 BCRL|DRUG: Placebo BCRL|DRUG: Placebo Food Effect
Sponsor: PureTech
Collaborators: Novotech (Australia) Pty Limited